FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to a plasmid structure encoding the spCas9 protein under the control of the CAG promoter and expressing sgRNA against a fragment of the sequence 1 exon of the hprt1 gene under the control of the U6 promoter. A method for obtaining a line of mice for modeling the Lesch-Nyhan syndrome containing a deletion of p.Val8del in the mHprt1 gene using the above plasmid construction is also disclosed.
EFFECT: invention is effective for a detailed study of the pathogenesis and development of therapy for the Lesch-Nyhan syndrome.
2 cl, 2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR OBTAINING A LINE OF HUMANIZED MICE CONTAINING 3974insT INSERTION IN THE mGrin2a GENE (MICE GLUTAMATE [NMDA] RECEPTOR SUBUNIT EPSILON-1), LEADING TO PREMATURE TERMINATION OF TRANSLATION OF THE grin2a PROTEIN | 2021 |
|
RU2764650C1 |
| METHOD FOR PRODUCING GENETICALLY MODIFIED LABORATORY ANIMALS WITH NULL ALLELE OF P2rx3 GENE | 2022 |
|
RU2805173C1 |
| METHOD OF PRODUCING MOUSE MODEL FOR STUDYING DUCHENNE MUSCULAR DYSTROPHY AND VERSIONS OF ITS THERAPY | 2023 |
|
RU2815936C1 |
| LINE OF MICE TRANSGENIC ON AN ALPHA-CHAIN OF A T-CELL RECEPTOR OF MEMORY CELLS, TO STUDY THEIR FUNCTIONAL ACTIVITY | 2017 |
|
RU2691484C2 |
| METHOD FOR OBTAINING A LINE OF HUMANISED MICE, TRANSGENIC BY hACE2 | 2020 |
|
RU2757114C1 |
| METHOD OF OBTAINING GENETICALLY MODIFIED LABORATORY ANIMALS WITH INDUCIBLE SYSTEMIC AND TISSUE-SPECIFIC EXPRESSION OF HUMAN CYCLOPHILIN A | 2022 |
|
RU2800264C1 |
| METHOD OF PRODUCING GENETICALLY MODIFIED MICE EXPRESSING HUMAN ANTITHROMBIN III MINIGENE USING MICROINJECTIONS OF TELN-LINEARIZED DNA FRAGMENT | 2022 |
|
RU2806568C1 |
| PDE6B GENE KNOCKOUT MOUSE MODEL CREATING AND APPLYING METHOD | 2022 |
|
RU2791687C1 |
| GENETIC DESIGN FOR EXPRESSION OF THE FUNCTIONALLY-ACTIVE HUMAN STRESS-PROTEIN (HPS70) WITH MUTATED GLYCOSILATION SITES FOR WORKING IN EUCARIOTIC EXPRESSION SYSTEMS | 2016 |
|
RU2647570C1 |
| TRANSGENIC MOUSE USED FOR INVESTIGATION OF REPARATIVE REGENERATION OF SKIN WOUND | 2023 |
|
RU2823992C1 |
